Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

27 Mar 2026 07:00

RNS Number : 3302Y
Chesnara PLC
27 March 2026
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

27th March 2026

 

CHESNARA plc

("Chesnara", "the Company" or the "Group")

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMRs')

 

Chesnara plc (CSN.L) announces that on 25th March 2026 and in accordance with the current Directors' Remuneration Policy, which was approved by shareholders on 16th May 2023, Group Chief Executive Steven Murray, Group Chief Financial Officer Thomas Howard, Group General Counsel Emma Dawe and Group Company Secretary Alastair Lonie (all PDMRs) were granted awards over the ordinary shares of the Company under the Chesnara plc 2023 Short Term Incentive Scheme and Chesnara plc 2023 Long Term Incentive Plan. 

The notifications for each PDMR below, which are being made in accordance with the requirements of the UK Market Abuse Regulations, provide further detail of the awards granted to each PDMR.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Steven Murray

2

Reason for the notification

a)

Position/status:

Group Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2023 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2023 Long Term Incentive Plan, the option is subject to performance targets over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

63,525 Ordinary shares of 5p each

 

 

Nil

GRANT 2

231,034 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 294,559 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2026-03-25

f)

Place of the transaction

XOFF

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Thomas Howard

2

Reason for the notification

a)

Position/status:

Group Chief Financial Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2023 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2023 Long Term Incentive Plan, the option is subject to performance targets over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

42,052 Ordinary shares of 5p each

 

 

Nil

GRANT 2

123,103 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 165,155 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2026-03-25

f)

Place of the transaction

XOFF

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Emma Dawe

2

Reason for the notification

a)

Position/status:

Group General Counsel

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2023 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2023 Long Term Incentive Plan, the option is subject to performance targets over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

10,028 Ordinary shares of 5p each

 

 

Nil

GRANT 2

47,293 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 57,321 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2026-03-25

f)

Place of the transaction

XOFF

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

Alastair Lonie

2

Reason for the notification

a)

Position/status:

Group Company Secretary

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2023 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2023 Long Term Incentive Plan, the option is subject to performance targets over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 25th March 2029 and remain exercisable up to and including 25th March 2036 if not exercised before that date.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

14,162 Ordinary shares of 5p each

 

 

Nil

GRANT 2

48,638 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 62,800 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2026-03-25

f)

Place of the transaction

XOFF

 

 

Name of authorised official of issuer responsible for making notification: -

Alastair Lonie, Group Company Secretary

 

Date of notification: - 27th March 2026

 

 

The above notification is made in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Misha Bayliss - +44 20 7427 5465

Oscar Burnett - +44 20 7427 5435

Teneo

E - chesnara@teneo.com

 

 

 

Notes to Editors

Chesnara plc (CSN.L) is a FTSE 250 European life, pensions and investment company with specialist expertise in consolidation. We now administer c1.4m policies across the Group's business units of Countrywide Assured and Chesnara Life (formerly HSBC Life (UK) Ltd) in the UK, Scildon in the Netherlands and Movestic in Sweden. Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing focused, profitable new business in the UK, Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios. Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 21 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPURUWUPQGQQ
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.